Centene Corp., US15135B1017

Centene Corp. provides 2026 earnings guidance: 21 analysts rate Centene Corp. stock Hold

Published on 10/02/2026 at 14:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Revenue hit USD 53.58 billion in the second quarter, up 9.90 percent year over year. Centene Corp. stock costs EUR 54.68 on October 2, 2026 after EUR 54.25.

Schwarzweiß-Reportagefoto eines Arbeiters im Pharmalager zwischen hohen Regalreihen
Cencora Inc. zeigt US15135B1017 einen Lagermitarbeiter der Medikamentenwagen durch enge Hochregalgänge in Schwarzweiß-Reportage schiebt, Illustration mit AI erstellt.

Centene Corp. (ISIN US15135B1017) was trading at EUR 54.68 at Lang & Schwarz on October 2, 2026 at 2:31 p.m. CEST. On September 16, 2026, MarketBeat reported that Centene provided fiscal 2026 earnings per share guidance of USD 4.80, while 21 analysts carried a consensus Hold rating.

Guidance sits below consensus

The USD 4.80 guidance stands below the USD 4.89 analyst consensus cited by MarketBeat on September 16, 2026. That gap of USD 0.09 per share places the company guidance below the current sell-side estimate, even as the latest reported quarter exceeded the comparable forecast.

Revenue beats the quarterly estimate

For the second quarter of 2026, Centene reported USD 53.58 billion in revenue, up 9.90 percent from the same period a year earlier, according to MarketBeat. Adjusted earnings per share reached USD 2.51 against a USD 1.09 consensus estimate, a USD 1.42 difference that gives the guidance revision a more complex backdrop.

The revenue figure also exceeded the USD 47.64 billion consensus estimate by USD 5.94 billion. Centene's managed-care exposure spans Medicaid, Medicare, commercial insurance and related healthcare services, making earnings per share guidance and revenue growth the two clearest measures of the current operating picture.

NYSE quote remains below yearly high

Centene's NYSE quote was last at USD 60.96 on October 1, 2026 at 3:59 p.m. ET. The USD 31.63 to USD 69.63 52-week range puts that quote 12.45 percent below the yearly high, while the market capitalization was USD 30.1 billion on the same date.

EUR 54.68 in trading

Centene Corp. stock was trading at EUR 54.68 at Lang & Schwarz on October 2, 2026 at 2:31 p.m. CEST, with a plus 0.79 percent change versus the EUR 54.25 prior close at Lang & Schwarz on October 1, 2026. The further course of trading is shown by the continuously updated real-time quote of Centene Corp stock.

Centene Corp. stock facts

  • Company: Centene Corp.
  • ISIN: US15135B1017
  • Ticker: CNC
  • Primary exchange: NYSE
  • Price Lang & Schwarz as of October 2, 2026, 2:31 p.m. CEST: EUR 54.68
  • Change versus prior close: plus 0.79 percent
  • Prior close Lang & Schwarz October 1, 2026: EUR 54.25
  • Market capitalization: USD 30.1 billion as of October 1, 2026
  • 52-week range: USD 31.63-69.63 as of October 1, 2026
  • Sector / Industry: Healthcare / Healthcare Providers and Services

More news and analyses on Centene Corp stock

Disclaimer...

en | US15135B1017 | CENTENE CORP. | boerse | 70215618 | bgmi